- Austria (PDF - 35.1KB)
- Belgium (Dutch) (PDF - 32.6KB)
- Belgium (French) (PDF - 94.8KB)
- Bulgaria (PDF - 147.4KB)
- Canada (English) (PDF - 107.6KB)
- Canada (French) (PDF - 142.8KB)
- Croatia (PDF - 200.5KB)
- Cyprus (PDF - 160.2KB)
- Czechia (PDF - 142.5KB)
- Denmark (PDF - 33.4KB)
- Estonia (PDF - 32.5KB)
- Finland (PDF - 127.1KB)
- France (PDF - 151.2KB)
- Germany (PDF - 24.1KB)
- Greece (PDF - 146.2KB)
- Hungary (PDF - 141.9KB)
- India (PDF - 300.3KB)
- Indonesia (PDF - 296.9KB)
- Ireland (PDF - 88.5KB)
- Israel (Prescription medicines and vaccines) (PDF - 171.3KB)
- Italy (PDF - 220.7KB)
- Latvia (PDF - 97.9KB)
- Lithuania (PDF - 144.3KB)
- Malta (PDF - 97.0KB)
- Mexico (PDF - 175.9KB)
- Norway (PDF - 108.7KB)
- Poland (PDF - 163.9KB)
- Portugal (PDF - 28.2KB)
- Romania (PDF - 148.7KB)
- Serbia & Montenegro (PDF - 99.8KB)
- Slovakia (PDF - 140.9KB)
- Slovenia (PDF - 137.7KB)
- Spain (PDF - 133.6KB)
- Sweden (PDF - 35.4KB)
- The Netherlands (PDF - 32.7KB)
- Turkey (PDF - 207.7KB)
- United Kingdom (PDF - 89.3KB)
- United States
Privacy Notice for submitting side effects, medical information queries and product complaints
Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your adverse event report, medical information enquiry or product quality complaint. If your location is not listed below, please refer to the GSK Privacy Centre for GSK’s general privacy notices for your location.
